We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
- Authors
Herold, Michael; Haas, Antje; Srock, Stefanie; Neser, Sabine; Al-Ali, Kathrin Haifa; Neubauer, Andreas; Dölken, Gottfried; Naumann, Ralph; Knauf, Wolfgang; Freund, Mathias; Rohrberg, Robert; Höffken, Klaus; Franke, Astrid; Ittel, Thomas; Kettner, Erika; Haak, Ursula; Mey, Ulrich; Klinkenstein, Christian; Assmann, Michael; von Grünhagen, Ullrich; East German Study Group Hematology and Oncology Study
- Abstract
Rituximab has been shown to be active in follicular lymphoma (FL), both as monotherapy and in combination with chemotherapy. We conducted a randomized trial comparing mitoxantrone, chlorambucil, and prednisolone (MCP) chemotherapy plus rituximab with MCP alone.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 15, p1986
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.06.4618